Formulation and Evaluation Immediate Release Mucoadhesive Buccal Tablet of Midodrine HCL
DOI:
https://doi.org/10.22270/ajprd.v12i4.1437Abstract
This study aimed to develop and optimize immediate-release mucoadhesive buccal tablets of Midodrine Hydrochloride, intended for rapid onset of action in treating hypotensive states. The tablets were prepared using a direct compression method, with various formulations optimized through a 32 randomized full factorial design, focusing on Crospovidone and Carbopol 934P as independent variables affecting diffusion time and mucoadhesive strength. The optimized batch F3 demonstrated superior performance, with a disintegration time of 20 seconds and an in vitro release of 98.25% within 5 minutes, meeting the criteria for immediate release. Additionally, F3 exhibited strong mucoadhesive strength, ensuring prolonged retention in the buccal cavity, and an appropriate surface pH of 6.8, compatible with the buccal environment. Stability studies conducted according to ICH guidelines confirmed that the optimized formulation maintained its integrity and efficacy under accelerated conditions. The findings suggest that the optimized F3 formulation is highly effective for buccal delivery of Midodrine Hydrochloride, offering a promising therapeutic option for patients requiring rapid antihypotensive action. The tablets exhibited efficient mucoadhesive strength, appropriate surface pH, and rapid drug release, making them promising for effective buccal drug delivery of Midodrine Hydrochloride.
Downloads
References
Smart JD. Buccal drug delivery. Expert opinion on drug delivery. 2005 May 1;2(3):507-17.
Shakya P, Madhav NS, Shakya AK, Singh K. Palatal mucosa as a route for systemic drug delivery: A review. Journal of controlled release. 2011 Apr 10;151(1):2-9.
Bhati, R. and Nagrajan, R.K., 2012. A detailed review on oral mucosal drug delivery system. International Journal of Pharmaceutical Sciences and Research, 3(3), p.659.
Patel M, Karigar A, Savaliya P, Ramana MV, Dubal A. Buccal drug delivery system: the current interest. Int J Pharm. 2011;2:12.
Harris D, Robinson JR. Drug delivery via the mucous membranes of the oral cavity. Journal of pharmaceutical sciences. 1992 Jan 1;81(1):1-0.
Peppas NA, Buri PA. Surface, interfacial and molecular aspects of polymer bioadhesion on soft tissues. Journal of Controlled Release. 1985 Nov 1;2:257-75.
Wertz PW, Swartzendruber DC, Squier CA. Regional variation in the structure and permeability of oral mucosa and skin. Advanced drug delivery reviews. 1993 Oct 1;12(1 2):1-2.
Carvalho FC, Bruschi ML, Evangelista RC, Gremião MP. Mucoadhesive drug delivery systems. Brazilian Journal of pharmaceutical sciences. 2010;46:1-7.
Jain PS, Bhadane P, Chaudhary HP, Surana SJ. Development and Validation of Zero and First-Order Derivative Area under Curve Spectrophotometric Methods for the Determination of Midodrine Hydrochloride in Bulk Material and in Pharmaceutical Dosage Form. Austin Chromatogr. 2018;5(1):1048.
McClellan KJ, Wiseman LR, Wilde MI. Midodrine: a review of its therapeutic use in the management of orthostatic hypotension. Drugs & aging. 1998 Jan; 12:75-86.
Rai VK, Pathak N, Bhaskar R, Nandi BC, Dey S and Tyagi LK. Optimization of immediate release tablet of Raloxifene Hydrochloride by wet granulation method. Int J Pharm Sci Drug research 2009; 1(1): 51-54.
Rabia B, Muhammad HS, Nousheen A, Durriya H and Masud-Ur- Rehman: Formulation development and optimization of Ibuprofen tablets by direct compression method. Pak J Pharm Science 2008; 21(2): 113-120.
Udgirkar DB, Hiremath SN, Rao KS, Pawar D. Formulation and in-vitro evaluation of buccoadhesive tablets containing ketoconazole inclusion complex with β-cyclodextrin.Research Journal of Pharmacy and Technology. 2009;2(2):396-404.
Deepthi BS, Rao MP, Ramakotaiah M, Durga CS, Suvarna CM. Formulation And Evaluation Of Pioglitazone Buccal Tablets.
Pandey SL, Hingawe NT, Das U, Patil AT. Mucoadhesive buccal tablets of domperidone: formulation evaluation and effects of process variables. Journal of Pharmaceutical Investigation. 2014 Apr;44:103-10.
Reddy J, Muzib YI, Chowdary KP. Development and characterization of novel trans buccoadhesive bilayer Tablets of tapentadol hydrochloride. Asian Journal of Research in Pharmaceutical Science. 2013;3(2):83-9.
Shabaraya A, Aiswarya K, Azharuddin M. Formulation and Evaluation of mucoadhesive bi layer buccal tablets of Labetalol hydrochloride using natural polymers. International Journal of Advances in Pharmacy, Biology and Chemistry (IJAPBC). 2012 Sep; 1:2277-4688.
Singh MK, Prajapati SK, Mahor A, Rajput N, Singh R. Formulation and in-vitro evaluation of microcrystalline chitosan based buccoadhesive bilayered tablets of repaglinide. Int J Pharm Biol Sci Arch. 2011;2(4):1282-90.
Çelik B. Risperidone mucoadhesive buccal tablets: formulation design, optimization and evaluation. Drug design, development and therapy. 2017 Nov 27:3355-65.
Reddy J, Muzib YI, Chowdary KP. Development and characterization of novel trans buccoadhesive bilayer Tablets of tapentadol hydrochloride. Asian Journal of Research in Pharmaceutical Science. 2013;3(2):83-9.
Ikinci G, Şenel SE, Wilson CG, Şumnu M. Development of a buccal bioadhesive nicotine tablet formulation for smoking cessation. International journal of pharmaceutics. 2004 Jun 11;277(1-2):173-8.
Minghetti P, Colombo A, Montanari L, Gaeta GM, Gombos F. Bucco adhesive slow-release tablets of acitretin: design and in vivo evaluation. International Journal of pharmaceutics. 1998 Jul 15;169(2):195-202.
Published
How to Cite
Issue
Section
Copyright (c) 2024 Aditi Vijay Tikait , Vikrant P. Wankhade , Yukta Mhaske, Sandeep C. Atram , Nishan N. Bobade , Pande S. D.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
.